JP2008525430A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008525430A5 JP2008525430A5 JP2007548113A JP2007548113A JP2008525430A5 JP 2008525430 A5 JP2008525430 A5 JP 2008525430A5 JP 2007548113 A JP2007548113 A JP 2007548113A JP 2007548113 A JP2007548113 A JP 2007548113A JP 2008525430 A5 JP2008525430 A5 JP 2008525430A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- hydrolyzate
- protein
- peptide
- dpp
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 29
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 15
- 108010067722 Dipeptidyl Peptidase 4 Proteins 0.000 claims description 13
- 102100025012 Dipeptidyl peptidase 4 Human genes 0.000 claims description 13
- 150000001413 amino acids Chemical class 0.000 claims description 9
- 239000003531 protein hydrolysate Substances 0.000 claims description 9
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims description 8
- 230000002401 inhibitory effect Effects 0.000 claims description 7
- 239000000203 mixture Substances 0.000 claims description 6
- 235000018102 proteins Nutrition 0.000 claims description 6
- 102000004169 proteins and genes Human genes 0.000 claims description 6
- 108090000623 proteins and genes Proteins 0.000 claims description 6
- 125000001500 prolyl group Chemical group [H]N1C([H])(C(=O)[*])C([H])([H])C([H])([H])C1([H])[H] 0.000 claims description 4
- 102000014171 Milk Proteins Human genes 0.000 claims description 3
- 108010011756 Milk Proteins Proteins 0.000 claims description 3
- 208000008589 Obesity Diseases 0.000 claims description 3
- 208000026278 immune system disease Diseases 0.000 claims description 3
- 230000001404 mediated effect Effects 0.000 claims description 3
- 235000021239 milk protein Nutrition 0.000 claims description 3
- 235000020824 obesity Nutrition 0.000 claims description 3
- 208000001072 type 2 diabetes mellitus Diseases 0.000 claims description 3
- 235000013361 beverage Nutrition 0.000 claims 6
- 235000015872 dietary supplement Nutrition 0.000 claims 6
- 235000013305 food Nutrition 0.000 claims 6
- 230000002265 prevention Effects 0.000 claims 5
- 239000000825 pharmaceutical preparation Substances 0.000 claims 2
- 229940127557 pharmaceutical product Drugs 0.000 claims 2
- 208000023275 Autoimmune disease Diseases 0.000 claims 1
- 208000023328 Basedow disease Diseases 0.000 claims 1
- 208000015023 Graves' disease Diseases 0.000 claims 1
- 108010009736 Protein Hydrolysates Proteins 0.000 claims 1
- 239000005018 casein Substances 0.000 claims 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 claims 1
- 235000021240 caseins Nutrition 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 201000006417 multiple sclerosis Diseases 0.000 claims 1
- 206010039073 rheumatoid arthritis Diseases 0.000 claims 1
- 229940024606 amino acid Drugs 0.000 description 7
- 235000001014 amino acid Nutrition 0.000 description 7
- 150000001875 compounds Chemical class 0.000 description 3
- 230000003389 potentiating effect Effects 0.000 description 3
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- 239000003112 inhibitor Substances 0.000 description 2
- 239000004471 Glycine Substances 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- 108010073771 Soybean Proteins Proteins 0.000 description 1
- 241000209140 Triticum Species 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 230000001976 improved effect Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 1
- 229960000310 isoleucine Drugs 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 239000004474 valine Substances 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP04078502 | 2004-12-23 | ||
| EP04078502.4 | 2004-12-23 | ||
| PCT/NL2005/050056 WO2006068480A2 (en) | 2004-12-23 | 2005-11-30 | Protein hydrolysate enriched in peptides inhibiting dpp-iv and their use |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2008525430A JP2008525430A (ja) | 2008-07-17 |
| JP2008525430A5 true JP2008525430A5 (cg-RX-API-DMAC7.html) | 2009-01-22 |
| JP5068174B2 JP5068174B2 (ja) | 2012-11-07 |
Family
ID=36602170
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007548113A Expired - Fee Related JP5068174B2 (ja) | 2004-12-23 | 2005-11-30 | Dpp−ivを阻害するペプチド中に濃縮されたタンパク質の加水分解物及びその使用 |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US8273710B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP1831361B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP5068174B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR101331777B1 (cg-RX-API-DMAC7.html) |
| AT (1) | ATE542896T1 (cg-RX-API-DMAC7.html) |
| DK (1) | DK1831361T3 (cg-RX-API-DMAC7.html) |
| ES (1) | ES2381118T3 (cg-RX-API-DMAC7.html) |
| TW (1) | TWI421089B (cg-RX-API-DMAC7.html) |
| WO (1) | WO2006068480A2 (cg-RX-API-DMAC7.html) |
Families Citing this family (58)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK1831361T3 (da) | 2004-12-23 | 2012-05-14 | Campina Nederland Holding Bv | Proteinhydrolysat beriget med peptider, som inhiberer DPP-IV, og deres anvendelse |
| US20100056458A1 (en) * | 2005-06-30 | 2010-03-04 | Campina Nederland Holding B.V. | Peptides Inhibiting Angiotensin-Converting Enzyme |
| JP2009517464A (ja) * | 2005-11-30 | 2009-04-30 | カンピーナ ネーダーランド ホールディング ビー.ブイ. | グルカゴン様ペプチド1の活性を増強するタンパク質加水分解物の使用 |
| EP1840133A1 (en) * | 2006-03-29 | 2007-10-03 | Global Biotech Development Corp. Ltd. | New immunomodulating oligopeptides |
| KR101652778B1 (ko) * | 2006-04-21 | 2016-08-31 | 가부시키가이샤 메이지 | 펩티드를 유효 성분으로서 함유하는 조성물 |
| KR20130140215A (ko) * | 2006-04-28 | 2013-12-23 | 유키지루시 메그밀크 가부시키가이샤 | 펩티드 |
| JP2008189637A (ja) * | 2007-02-08 | 2008-08-21 | Snow Brand Milk Prod Co Ltd | 自己免疫疾患予防剤 |
| GB2451858A (en) * | 2007-08-15 | 2009-02-18 | Sergiy Konovchuk | Methods of reducing body fat and treating obesity |
| KR20100057061A (ko) * | 2007-09-11 | 2010-05-28 | 몬도바이오테크 래보래토리즈 아게 | 치료제로서의 펩티드 maippkknqdk (소 카파 카세인 106-116)및/또는 ygfqna (세로르핀)의 용도 |
| WO2009128713A1 (en) * | 2008-04-14 | 2009-10-22 | Newtricious B.V. | Egg protein hydrolysates |
| DE102008062136B4 (de) * | 2008-12-16 | 2012-05-03 | Kamamed Ug | Pharmazeutische Zusammensetzung auf Basis von Peptid aus Kamelmilch |
| WO2010087480A1 (ja) * | 2009-02-02 | 2010-08-05 | 国立大学法人京都大学 | ペプチドを含む医薬または食品 |
| JP5735734B2 (ja) * | 2009-04-16 | 2015-06-17 | 雪印メグミルク株式会社 | 脂質代謝改善剤 |
| JP2011084485A (ja) * | 2009-10-13 | 2011-04-28 | Snow Brand Milk Prod Co Ltd | 脂肪蓄積抑制剤 |
| EP2540308A1 (en) * | 2010-02-24 | 2013-01-02 | Morinaga Milk Industry Co., Ltd. | Therapeutic agent for eating disorders |
| CA2798591A1 (en) * | 2010-05-12 | 2011-11-17 | Mapi Pharma Limited | Polymorphs of alogliptin benzoate |
| CN103108957B (zh) * | 2010-08-24 | 2015-07-01 | 武汉九生堂生物工程有限公司 | 全蛋蛋白肽及其制备方法和应用 |
| JP5832049B2 (ja) * | 2012-03-09 | 2015-12-16 | 森永乳業株式会社 | ジペプチジルペプチダーゼ−iv阻害剤 |
| JP5976004B2 (ja) * | 2012-03-09 | 2016-08-23 | 森永乳業株式会社 | ジペプチジルペプチダーゼ−iv阻害剤 |
| WO2014060495A1 (en) * | 2012-10-19 | 2014-04-24 | Dsm Ip Assets B.V. | Process for the production of an infant formula |
| CN103232526B (zh) * | 2012-12-12 | 2015-06-24 | 上海交通大学 | 一种生物活性多肽lplp及其制备和应用 |
| US9138455B2 (en) * | 2013-03-15 | 2015-09-22 | Mead Johnson Nutrition Company | Activating adiponectin by casein hydrolysate |
| US9345727B2 (en) | 2013-03-15 | 2016-05-24 | Mead Johnson Nutrition Company | Nutritional compositions containing a peptide component and uses thereof |
| US9345741B2 (en) * | 2013-03-15 | 2016-05-24 | Mead Johnson Nutrition Company | Nutritional composition containing a peptide component with adiponectin simulating properties and uses thereof |
| US8889633B2 (en) | 2013-03-15 | 2014-11-18 | Mead Johnson Nutrition Company | Nutritional compositions containing a peptide component with anti-inflammatory properties and uses thereof |
| US9352020B2 (en) * | 2013-03-15 | 2016-05-31 | Mead Johnson Nutrition Company | Reducing proinflammatory response |
| US9289461B2 (en) | 2013-03-15 | 2016-03-22 | Mead Johnson Nutrition Company | Reducing the risk of autoimmune disease |
| JP5952967B2 (ja) | 2013-06-12 | 2016-07-13 | マルハニチロ株式会社 | ジペプチジルペプチダーゼiv(dppiv)阻害ペプチド化合物、それを含有する組成物、及びその製造方法 |
| CN103483418B (zh) * | 2013-09-12 | 2015-04-01 | 陈尚武 | 一种dpp-ⅳ抑制多肽及其应用 |
| US10639334B2 (en) * | 2014-01-07 | 2020-05-05 | Mead Johnson Nutrition Company | Pediatric nutritional composition with milk peptides for healthy growth and development |
| FR3017536B1 (fr) * | 2014-02-18 | 2017-05-26 | Univ La Rochelle | Compositions pour la prevention et/ou le traitement de pathologies liees a l'alpha-glucosidase |
| JP5872725B1 (ja) * | 2015-02-26 | 2016-03-01 | ヤマキ株式会社 | 鰹節由来のジペプチジルペプチダーゼiv阻害組成物 |
| JP2017031105A (ja) * | 2015-08-03 | 2017-02-09 | 森永乳業株式会社 | 食後血糖値の上昇抑制を促進させる剤 |
| CN105341949B (zh) * | 2015-10-09 | 2018-03-27 | 滨州万嘉生物科技有限公司 | 一种具有降血糖功能的鱼肉蛋白肽及其制备方法与应用 |
| WO2017117121A1 (en) * | 2015-12-28 | 2017-07-06 | Abbott Laboratories | Nutritional compositions comprising hydrolyzed protein and a modified fat system and uses thereof |
| EP3590519A4 (en) * | 2017-03-03 | 2020-12-16 | Morinaga Milk Industry Co., Ltd. | GLP-1 SECRETAGOGUE AND COMPOSITION |
| MX2019011060A (es) * | 2017-03-16 | 2019-12-09 | Microsintesis Inc | Composiciones y metodos que involucran moleculas probioticas. |
| SG11201909606RA (en) | 2017-03-16 | 2019-11-28 | Microsintesis Inc | Probiotic molecules for reducing pathogen virulence |
| CN108314705B (zh) * | 2018-01-26 | 2020-07-14 | 海普诺凯营养品有限公司 | 具有dpp-iv抑制功能的羊乳清蛋白肽、其制备方法及其应用 |
| CN108935912B (zh) * | 2018-06-21 | 2021-04-23 | 中国农业大学 | 一种具有dpp-ⅳ抑制和抗疲劳功能的鱼肉蛋白肽及其制备方法 |
| JP7068942B2 (ja) * | 2018-06-25 | 2022-05-17 | サンスター株式会社 | トリペプチド含有組成物 |
| WO2021083958A1 (en) * | 2019-10-29 | 2021-05-06 | Specialites Pet Food | Novel peptides inducing satiety |
| CN114621320B (zh) * | 2020-12-14 | 2024-05-24 | 清华大学 | 一种可用于减缓glp-1酶解的短肽及其组合物 |
| WO2022186290A1 (ja) * | 2021-03-02 | 2022-09-09 | 森永乳業株式会社 | ジペプチジルペプチダーゼ-iv阻害剤 |
| CN113035291B (zh) * | 2021-04-08 | 2022-04-05 | 广东药科大学 | 计算机辅助药物设计dpp-iv抑制肽的方法、dpp-iv抑制肽及其应用 |
| CN113480605A (zh) * | 2021-07-27 | 2021-10-08 | 中国海洋大学 | 一种牦牛乳酪蛋白dpp-iv抑制肽及其筛选方法 |
| JP2023069271A (ja) | 2021-11-05 | 2023-05-18 | 住友化学株式会社 | Dpp-4阻害剤およびその製造方法。 |
| CN114686551B (zh) * | 2022-03-16 | 2023-08-08 | 江南大学 | 一种豌豆蛋白源dpp-iv抑制肽及其筛选方法 |
| CN114836491B (zh) * | 2022-05-30 | 2023-03-14 | 广州恒雅生物化工有限公司 | 一种抗老亮肤的肌肽制备方法及其在化妆品的应用 |
| WO2024038888A1 (ja) * | 2022-08-19 | 2024-02-22 | 森永乳業株式会社 | 組成物 |
| CN115252759A (zh) * | 2022-08-24 | 2022-11-01 | 四川大学华西第二医院 | 酸奶衍生多肽在制备延缓端粒缩短药物及抗衰老药物中的应用 |
| CN116284234B (zh) * | 2023-02-09 | 2024-11-08 | 昆明理工大学 | 一种驼乳源小分子肽及其应用 |
| CN117598389A (zh) * | 2023-11-13 | 2024-02-27 | 大连工业大学 | 一种具有增强免疫功能的酪蛋白水解物及其制备方法 |
| CN117624290A (zh) * | 2023-11-30 | 2024-03-01 | 澳优乳业(中国)有限公司 | 羊乳酪蛋白酶解多肽及其组合物、筛选方法和用途 |
| CN118620029B (zh) * | 2024-05-27 | 2024-12-20 | 合肥工业大学 | 一种干腌火腿源dpp-iv抑制肽及其制备、鉴定方法和应用 |
| CN118894920B (zh) * | 2024-10-09 | 2025-04-04 | 澳优乳业(中国)有限公司 | 一种具有降血糖作用的功能肽及制备方法和应用 |
| CN120098106B (zh) * | 2025-05-08 | 2025-08-22 | 华南理工大学 | 一种酪蛋白源降血糖肽及其应用 |
| CN120718130B (zh) * | 2025-08-15 | 2025-12-30 | 杭州康源食品科技有限公司 | 一种促钙吸收利用的酪蛋白源七肽及其应用 |
Family Cites Families (39)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5681586A (en) | 1989-03-23 | 1997-10-28 | Gordon; Arthur L. | Enzyme-modified soy and soy/casein combination healing compositions |
| JP3119674B2 (ja) | 1991-02-15 | 2000-12-25 | 日本合成化学工業株式会社 | 新規ペプチド、その製造法及び用途 |
| DE4211878C2 (de) | 1992-04-09 | 1995-04-20 | Ralf Dr Med Kluge | Mittel zur Behandlung der Multiplen Sklerose |
| WO1994011689A1 (en) * | 1992-11-19 | 1994-05-26 | Yu Tom Yen Shing | Paper sheet coating apparatus with gas streams drying |
| US5405637A (en) | 1993-06-30 | 1995-04-11 | Bristol-Myers Squibb Company | Milk protein partial hydrolysate and infant formula containing same |
| JP3665663B2 (ja) | 1994-08-02 | 2005-06-29 | カルピス株式会社 | 血圧降下剤及びその製造法 |
| WO1998002165A1 (en) | 1996-07-17 | 1998-01-22 | Nutracorp Scientific, Inc. | Appetite suppression |
| DE19828114A1 (de) * | 1998-06-24 | 2000-01-27 | Probiodrug Ges Fuer Arzneim | Produgs instabiler Inhibitoren der Dipeptidyl Peptidase IV |
| CA2296311A1 (en) * | 1999-01-28 | 2000-07-28 | Universite Laval | Enzymatic hydrolysate of milk proteins |
| EP1034704A1 (en) | 1999-03-12 | 2000-09-13 | Societe Des Produits Nestle S.A. | Nutritional composition intended for specific gastro-intestinal maturation in premature mammals |
| AU5382200A (en) * | 1999-06-15 | 2001-01-02 | University Health Network | Muc1 ligands |
| US20040152745A1 (en) | 1999-11-12 | 2004-08-05 | Guilford Pharmaceuticals, Inc. | Dipeptidyl peptidase IV inhibitors and methods of making and using dipeptidyl peptidase IV inhibitors |
| GB9927603D0 (en) | 1999-11-22 | 2000-01-19 | Nestle Sa | Use of a milk protein hydrolysate in the treatment of diabetes |
| AU2000269178A1 (en) | 2000-08-17 | 2002-02-25 | The University Of Texas System | Use of colostrinin, constituent peptides thereof, and analogs thereof as oxidative stress regulators |
| ATE328491T1 (de) | 2000-10-24 | 2006-06-15 | Campina Melkunie Bv | Peptiden reich an cystein und/oder glycin |
| DK1339837T3 (da) | 2000-12-07 | 2008-06-09 | Dsm Ip Assets Bv | Prolyl-endoprotease fra Aspergillus Niger |
| EP1365656A1 (en) | 2001-03-09 | 2003-12-03 | Unilever N.V. | Fermented milk product |
| JP2002284668A (ja) | 2001-03-26 | 2002-10-03 | Cosmo Products Kk | クスミの予防・治療剤 |
| FR2825004B1 (fr) | 2001-05-22 | 2005-02-11 | Bio Springer | Produit dietetique satiant |
| RU2299066C2 (ru) * | 2001-06-27 | 2007-05-20 | Пробиодруг Аг | Новые ингибиторы дипептидилпептидазы iv и их применение в качестве противораковых агентов |
| US20050013867A1 (en) | 2001-10-19 | 2005-01-20 | Lehrman S. Russ | Use of proton sequestering agents in drug formulations |
| US20030165574A1 (en) | 2002-03-01 | 2003-09-04 | Ward Loren Spencer | Compositions and methods for treatment of body weight conditions |
| US20040009956A1 (en) * | 2002-04-29 | 2004-01-15 | Dehua Pei | Inhibition of protein tyrosine phosphatases and SH2 domains by a neutral phosphotyrosine mimetic |
| DE60227922D1 (de) | 2002-05-27 | 2008-09-11 | Nestec Sa | Säurelösliche Proteine aus Casein-Micellen |
| EP1509609B1 (en) | 2002-06-04 | 2015-04-22 | DSM IP Assets B.V. | Protein hydrolysate rich in tripeptides |
| GB0213612D0 (en) | 2002-06-13 | 2002-07-24 | Novartis Nutrition Ag | Organic compounds |
| EP1517619B1 (en) | 2002-07-01 | 2007-01-03 | Unilever N.V. | Satiety inducing composition |
| WO2004022083A1 (en) | 2002-09-04 | 2004-03-18 | Dsm Ip Assets B.V. | A nutritional and therapeutic composition of an insulin sensitizer and a peptide fraction |
| AU2003265010A1 (en) | 2002-09-16 | 2004-04-30 | Quest International Services B.V. | Method of treating or preventing obeisity and lipid metabolism disorders and compositions for use therein |
| ATE469645T1 (de) * | 2002-10-23 | 2010-06-15 | Bristol Myers Squibb Co | Auf glycinnitril basierende hemmer der dipeptidylpeptidase iv |
| EP1422293A1 (en) | 2002-11-25 | 2004-05-26 | F. Hoffmann-La Roche Ag | Crystal structure of dipeptidyl peptidase IV |
| US20070015269A1 (en) * | 2002-11-25 | 2007-01-18 | Michael Hennig | Crystals of DPP-IV |
| DK1599215T3 (da) | 2003-02-07 | 2010-11-15 | Campina Bv | Anvendelse af tryptophanrige peptider fra mælkeproteinhydrolysat til behandling af overvægt og fedme |
| GB0310593D0 (en) * | 2003-05-08 | 2003-06-11 | Leuven K U Res & Dev | Peptidic prodrugs |
| KR20070007128A (ko) | 2004-03-01 | 2007-01-12 | 펩테라 파마슈티컬스 엘티디. | 카제인 파생 펩타이드들과 그의 치료적 사용들 |
| US20080221023A1 (en) | 2004-05-27 | 2008-09-11 | Campina Nederland Holding | Use of Protein Hydrolysates For the Manufacture of a Medicament For Prophylaxis and/or Treatment of a Dpp-IV Mediated Condition |
| WO2006005757A2 (en) | 2004-07-12 | 2006-01-19 | Dsm Ip Assets B.V. | Blood pressure lowering oligopeptides |
| DK1831361T3 (da) | 2004-12-23 | 2012-05-14 | Campina Nederland Holding Bv | Proteinhydrolysat beriget med peptider, som inhiberer DPP-IV, og deres anvendelse |
| JP2009517464A (ja) | 2005-11-30 | 2009-04-30 | カンピーナ ネーダーランド ホールディング ビー.ブイ. | グルカゴン様ペプチド1の活性を増強するタンパク質加水分解物の使用 |
-
2005
- 2005-11-30 DK DK05809074.7T patent/DK1831361T3/da active
- 2005-11-30 WO PCT/NL2005/050056 patent/WO2006068480A2/en not_active Ceased
- 2005-11-30 KR KR1020077014235A patent/KR101331777B1/ko not_active Expired - Fee Related
- 2005-11-30 ES ES05809074T patent/ES2381118T3/es not_active Expired - Lifetime
- 2005-11-30 AT AT05809074T patent/ATE542896T1/de active
- 2005-11-30 EP EP05809074A patent/EP1831361B1/en not_active Expired - Lifetime
- 2005-11-30 JP JP2007548113A patent/JP5068174B2/ja not_active Expired - Fee Related
- 2005-11-30 US US11/722,667 patent/US8273710B2/en not_active Expired - Fee Related
- 2005-12-01 TW TW094142261A patent/TWI421089B/zh not_active IP Right Cessation
-
2012
- 2012-09-14 US US13/620,474 patent/US20130096074A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Fan et al. | Identification and characterization of gastrointestinal-resistant angiotensin-converting enzyme inhibitory peptides from egg white proteins | |
| Daliri et al. | Current trends and perspectives of bioactive peptides | |
| Romero-Garay et al. | Bioactivity of peptides obtained from poultry by-products: A review | |
| Nuchprapha et al. | Two novel ACE inhibitory peptides isolated from longan seeds: Purification, inhibitory kinetics and mechanisms | |
| Salampessy et al. | Functional and potential therapeutic ACE-inhibitory peptides derived from bromelain hydrolysis of trevally proteins | |
| Hayes et al. | Boarfish protein recovery using the pH-shift process and generation of protein hydrolysates with ACE-I and antihypertensive bioactivities in spontaneously hypertensive rats | |
| Zhang et al. | Comparison of dipeptidyl peptidase IV-inhibitory activity of peptides from bovine and caprine milk casein by in silico and in vitro analyses | |
| JP5068174B2 (ja) | Dpp−ivを阻害するペプチド中に濃縮されたタンパク質の加水分解物及びその使用 | |
| Memarpoor-Yazdi et al. | Structure and ACE-inhibitory activity of peptides derived from hen egg white lysozyme | |
| Kaewsahnguan et al. | A novel angiotensin I-converting enzyme inhibitory peptide derived from the trypsin hydrolysates of salmon bone proteins | |
| JP2015525768A (ja) | 抗炎症活性を有するペプチド、及びそれを含む組成物 | |
| JP2010520274A (ja) | ホエーからのace抑制ペプチド及び同物を提供する方法 | |
| WO2004014940A3 (en) | PEPTIDES AS SOLUBILIZING EXCIPIENTS FOR TRANSFORMING GROWTH FACTOR ß PROTEINS | |
| TW200940080A (en) | Process for preparing peptide products for promoting cholecystokinin secretion and use of the peptide products | |
| JP2010163400A (ja) | 新規アンジオテンシン変換酵素阻害ペプチド | |
| CN104736552A (zh) | 用于预防或治疗心血管疾病的、包含对血管紧张素-i转换酶表现出抑制活性的肽作为活性成分的药物组合物 | |
| JP5799842B2 (ja) | アンジオテンシン変換酵素阻害ペプチド、該ペプチドを含有するアンジオテンシン変換酵素阻害剤、組成物及び食品、並びに、該ペプチドの製造方法 | |
| Pihlanto et al. | The function of renin and the role of food-derived peptides as direct renin inhibitors | |
| Gildberg et al. | Angiotensin I-converting enzyme inhibitory activity in a hydrolysate of proteins from Northern shrimp (Pandalus borealis) and identification of two novel inhibitory tri-peptides | |
| WO2001027136A3 (fr) | Peptides ayant une activite de stimulation de la reponse immunitaire et de regeneration tissulaire | |
| JP5771522B2 (ja) | αS1カゼイン由来ペプチドを含む抗不安薬組成物 | |
| ZHANG et al. | A novel angiotensin I converting enzyme inhibitory peptide from the milk casein: Virtual screening and docking studies | |
| Guang et al. | Purification, activity and sequence of angiotensin I converting enzyme inhibitory peptide from alcalase hydrolysate of peanut flour | |
| WO2003062266A3 (en) | Hybrid synthetic method for antimicrobial peptides | |
| Ko et al. | Isolation and Activity Evaluation of Peptides with Anti-hypertensive Activity from Commercial Enzymatic Flounder Fish Hydrolysate |